Walgreens (NYSE:WAG) has declared its regular quarterly dividend of $0.1375 per share. The dividend is 22.2% higher than the dividend of the year before. This quarter’s dividend will be payable March 12, 2010 to shareholders of record on February 18, 2010.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The company has paid a dividend in 309 straight quarters. It’s dividend has increased at an annual compound rate of over 20% over the past five years. More information may be found by contacting Tiffani Washington of Walgreens at 847.914.2925.
Walgreen Co. (Walgreens) is engaged in retail drugstore business. As of August 31, 2009, the Company operated 7,496 locations in 50 states, the District of Columbia, Puerto Rico and Guam. During the fiscal year ended August 30, 2009 (fiscal 2009), the Company opened or acquired 691 locations. Total locations do not include 337 convenient care clinics operated by Take Care Health Systems, Inc. within the Company’s drugstores. The Company’s drugstores are engaged in the retail sale of prescription and non-prescription drugs and general merchandise. General merchandise includes, among other things, household items, personal care, convenience foods, beauty care, photofinishing, candy, and seasonal items. Walgreens offers customers the choice to have prescriptions filled at the drugstore counter, as well as through the mail, by telephone and through the Internet.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
